| ||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
Search results for: "N"
Results 51 - 60 of 277 shown below 
|
||||||||
|
||||||||
|
||||||||
|
||||||||
| neoadjuvant androgen deprivation C C Parker, A R Norman, R A Huddart, A Horwich and D P Dearnaley Pre-treatment nomogram for biochemical control after neoadjuvant androgen deprivation and radical radiotherapy for clinically localised prostate cancer doi:10.1038/sj.bjc.6600160 Abstract | Full article | PDF |
||||||||
| neoadjuvant chemoradiotherapy G Klautke, P Feyerherd, K Ludwig, F Prall, T Foitzik and R Fietkau Intensified concurrent chemoradiotherapy with 5-fluorouracil and irinotecan as neoadjuvant treatment in patients with locally advanced rectal cancer advance online publication, 2005-03-22 00:00:00.000; doi:10.1038/sj.bjc.6602492 Abstract | Full article | PDF G Klautke, U Küchenmeister, T Foitzik, K Ludwig, F Prall, E Klar and R Fietkau Concurrent chemoradiation with capecitabine and weekly irinotecan as preoperative treatment for rectal cancer: results from a phase I/II study advance online publication, 2006-03-21 00:00:00.000; doi:10.1038/sj.bjc.6603053 Abstract | Full article | PDF I Craven, A Crellin, R Cooper, A Melcher, P Byrne and D Sebag-Montefiore Preoperative radiotherapy combined with 5 days per week capecitabine chemotherapy in locally advanced rectal cancer advance online publication, 2007-11-06 00:00:00.000; doi:10.1038/sj.bjc.6604042 Abstract | Full article | PDF |
||||||||
| neoadjuvant chemotherapy C H Yang, C M Tsai, L S Wang, Y C Lee, C J Chang, L T Lui, S H Yen, C Hsu, A L Cheng, M Y Liu, S C Chiang, Y M Chen, K T Luh, M H Huang, P-C Yang and R-P Perng Gemcitabine and cisplatin in a multimodality treatment for locally advanced non-small cell lung cancer doi:10.1038/sj.bjc.6600044 Abstract | Full article | PDF H Bonnefoi, A Ducraux, S Movarekhi, M F Pelte, S Bongard, E Lurati and R Iggo p53 as a potential predictive factor of response to chemotherapy: feasibility of p53 assessment using a functional test in yeast from trucut biopsies in breast cancer patients doi:10.1038/sj.bjc.6600105 Abstract | Full article | PDF P Chollet, S Amat, H Cure, M de Latour, G Le Bouedec, M-A Mouret-Reynier, J-P Ferriere, J-L Achard, J Dauplat and F Penault-Llorca Prognostic significance of a complete pathological response after induction chemotherapy in operable breast cancer doi:10.1038/sj.bjc.6600210 Abstract | Full article | PDF I F Faneyte, J G Schrama, J L Peterse, P L Remijnse, S Rodenhuis and M J van de Vijver Breast cancer response to neoadjuvant chemotherapy: predictive markers and relation with outcome doi:10.1038/sj.bjc.6600749 Abstract | Full article | PDF I Chau, M Allen, D Cunningham, D Tait, G Brown, M Hill, K Sumpter, A Rhodes, A Wotherspoon, A R Norman, A Hill, A Massey and Y Prior Neoadjuvant systemic fluorouracil and mitomycin C prior to synchronous chemoradiation is an effective strategy in locally advanced rectal cancer doi:10.1038/sj.bjc.6600822 Abstract | Full article | PDF P Chollet, S Amat, E Belembaogo, H Curé, M de Latour, J Dauplat, G Le Bouëdec, M-A Mouret-Reynier, J-P Ferrière and F Penault-Llorca Is Nottingham prognostic index useful after induction chemotherapy in operable breast cancer? doi:10.1038/sj.bjc.6601258 Abstract | Full article | PDF A E Ring, I E Smith, A E Ring, I E Smith, S Ashley, L G Fulford, S Ashley, S R Lakhani, L G Fulford and S R Lakhani Oestrogen receptor status, pathological complete response and prognosis in patients receiving neoadjuvant chemotherapy for early breast cancer advance online publication, 2004-11-23 00:00:00.000; doi:10.1038/sj.bjc.6602235 Abstract | Full article | PDF R J Burcombe, A Makris, P I Richman, F M Daley, S Noble, M Pittam, D Wright, S A Allen, J Dove and G D Wilson Evaluation of ER, PgR, HER-2 and Ki-67 as predictors of response to neoadjuvant anthracycline chemotherapy for operable breast cancer advance online publication, 2004-12-21 00:00:00.000; doi:10.1038/sj.bjc.6602256 Abstract | Full article | PDF R L Jones, S R Lakhani, A E Ring, S Ashley, G Walsh and I E Smith Pathological complete response and residual DCIS following neoadjuvant chemotherapy for breast carcinoma advance online publication, 2006-01-17 00:00:00.000; doi:10.1038/sj.bjc.6602950 Abstract | Full article | PDF R Glynne-Jones, J Grainger, M Harrison, P Ostler and A Makris Neoadjuvant chemotherapy prior to preoperative chemoradiation or radiation in rectal cancer: should we be more cautious? doi:10.1038/sj.bjc.6602960 Abstract | Full article | PDF J-Y Pierga, J S Reis-Filho, S J Cleator, T Dexter, A MacKay, P Simpson, K Fenwick, M Iravani, J Salter, M Hills, C Jones, A Ashworth, I E Smith, T Powles and M Dowsett Microarray-based comparative genomic hybridisation of breast cancer patients receiving neoadjuvant chemotherapy advance online publication, 2006-11-28 00:00:00.000; doi:10.1038/sj.bjc.6603483 Abstract | Full article | PDF F K S Welsh, H S Tilney, P P Tekkis, T G John and M Rees Safe liver resection following chemotherapy for colorectal metastases is a matter of timing advance online publication, 2007-03-13 00:00:00.000; doi:10.1038/sj.bjc.6603670 Abstract | Full article | PDF P Kolodziejczyk, A Pituch-Noworolska, G Drabik, J Kulig, A Szczepanik, M Sierzega, A Gurda, T Popiela and M Zembala The effects of preoperative chemotherapy on isolated tumour cells in the blood and bone marrow of gastric cancer patients advance online publication, 2007-08-14 00:00:00.000; doi:10.1038/sj.bjc.6603904 Abstract | Full article | PDF M Bhattacharyya, D Ryan, R Carpenter, S Vinnicombe and C J Gallagher Using MRI to plan breast-conserving surgery following neoadjuvant chemotherapy for early breast cancer advance online publication, 2008-01-22 00:00:00.000; doi:10.1038/sj.bjc.6604171 Abstract | Full article | PDF T Sugiyama, T Nishida, S Kumagai, S Nishio, K Fujiyoshi, N Okura, M Yakushiji, M Hiura and N Umesaki Combination therapy with irinotecan and cisplatin as neoadjuvant chemotherapy in locally advanced cervical cancer doi:10.1038/sj.bjc.6690656 Abstract | Full article | PDF J-Y Pierga, E Mouret, V Diéras, V Laurence, P Beuzeboc, T Dorval, T Palangié, M Jouve, A Vincent-Salomon, S Scholl, J-M Extra, B Asselain and P Pouillart Prognostic value of persistent node involvement after neoadjuvant chemotherapy in patients with operable breast cancer doi:10.1054/bjoc.2000.1461 Abstract | Full article | PDF |
||||||||
| neoadjuvant chemotherapy (NACT) N R Jagannathan, M Kumar, V Seenu, O Coshic, S N Dwivedi, P K Julka, A Srivastava and G K Rath Evaluation of total choline from in-vivo volume localized proton MR spectroscopy and its response to neoadjuvant chemotherapy in locally advanced breast cancer doi:10.1054/bjoc.2000.1711 Abstract | Full article | PDF |
||||||||
| neoadjuvant therapy W R Miller, M Stuart, T Sahmoud and J M Dixon Anastrozole ('Arimidex') blocks oestrogen synthesis both peripherally and within the breast in postmenopausal women with large operable breast cancer doi:10.1038/sj.bjc.6600587 Abstract | Full article | PDF W R Miller, S White, J M Dixon, J Murray, L Renshaw and T J Anderson Proliferation, steroid receptors and clinical/pathological response in breast cancer treated with letrozole advance online publication, 2006-03-14 00:00:00.000; doi:10.1038/sj.bjc.6603001 Abstract | Full article | PDF P K Julka, R T Chacko, S Nag, R Parshad, A Nair, D S Oh, Z Hu, C B Koppiker, S Nair, R Dawar, N Dhindsa, I D Miller, D Ma, B Lin, B Awasthy and C M Perou A phase II study of sequential neoadjuvant gemcitabine plus doxorubicin followed by gemcitabine plus cisplatin in patients with operable breast cancer: prediction of response using molecular profiling advance online publication, 2008-04-01 00:00:00.000; doi:10.1038/sj.bjc.6604322 Abstract | Full article | PDF |
||||||||
| neomycin S K Panda, S C Chattoraj and S A Broitman Correlation of neomycin, faecal neutral and acid sterols with colon carcinogenesis in rats doi:10.1038/sj.bjc.6690476 Abstract | Full article | PDF |
||||||||
| neonatal cardiac myocytes M A I Abou El Hassan, M J W E Rabelink, W J F van der Vijgh, A Bast and R C Hoeben A comparative study between catalase gene therapy and the cardioprotector monohydroxyethylrutoside (MonoHER) in protecting against doxorubicin-induced cardiotoxicity in vitro doi:10.1038/sj.bjc.6601430 Abstract | Full article | PDF |
||||||||
| Neoplasia S E H Russell and P A Hall Do septins have a role in cancer? doi:10.1038/sj.bjc.6602753 Abstract | Full article | PDF D E Brenner and A J Gescher Cancer chemoprevention: lessons learned and future directions advance online publication, 2005-09-06 00:00:00.000; doi:10.1038/sj.bjc.6602765 Abstract | Full article | PDF |
||||||||
| neoplasias F de Nigris, J Cerutti, C Morelli, D Califano, L Chiariotti, G Viglietto, G Santelli and A Fusco Isolation of a SIR-like gene, SIR-T8, that is overexpressed in thyroid carcinoma cell lines and tissues doi:10.1038/sj.bjc.6600156 Abstract | Full article | PDF |
||||||||
| neoplasm D G Allen, A-M Hutchins, F Hammet, D J White, J P Scurry, S N Tabrizi, S M Garland and J E Armes Genetic aberrations detected by comparative genomic hybridisation in vulvar cancers doi:10.1038/sj.bjc.6600112 Abstract | Full article | PDF H Sasamura, A Takahashi, N Miyao, M Yanase, N Masumori, H Kitamura, N Itoh and T Tsukamoto Inhibitory effect on expression of angiogenic factors by antiangiogenic agents in renal cell carcinoma doi:10.1038/sj.bjc.6600152 Abstract | Full article | PDF K-W Chang, T-C Lee, W-I Yeh, M-Y Chung, C-J Liu, L-Y Chi and S-C Lin Polymorphism in heme oxygenase-1 (HO-1) promoter is related to the risk of oral squamous cell carcinoma occurring on male areca chewers advance online publication, 2004-09-14 00:00:00.000; doi:10.1038/sj.bjc.6602186 Abstract | Full article | PDF S K Maitra, H Gallo, C Rowland-Payne, D Robinson and H Møller Second primary cancers in patients with squamous cell carcinoma of the skin advance online publication, 2004-12-21 00:00:00.000; doi:10.1038/sj.bjc.6602306 Abstract | Full article | PDF J Lagergren and C Jansson Sex hormones and oesophageal adenocarcinoma: influence of childbearing? advance online publication, 2005-09-27 00:00:00.000; doi:10.1038/sj.bjc.6602810 Abstract | Full article | PDF D Mackerras, L Irwig, E Weisberg, M Cardona, F Webster, L Walton and D Ghersi Randomized double-blind trial of beta-carotene and vitamin C in women with minor cervical abnormalities doi:10.1038/sj.bjc.6690231 Abstract | Full article | PDF G I Murray, M C E McFadyen, R T Mitchell, Y-L Cheung, A C Kerr and W T Melvin Cytochrome P450 CYP3A in human renal cell cancer doi:10.1038/sj.bjc.6690292 Abstract | Full article | PDF A J Russell, J Sibbald, H Haak, W N Keith and A M McNicol Increasing genome instability in adrenocortical carcinoma progression with involvement of chromosomes 3, 9 and X at the adenoma stage doi:10.1038/sj.bjc.6690748 Abstract | Full article | PDF S B Middleton, I M Frayling and R K S Phillips Desmoids in familial adenomatous polyposis are monoclonal proliferations doi:10.1054/bjoc.1999.1007 Abstract | Full article | PDF T Kamai, K Takagi, H Asami, Y Ito, H Oshima and K-I Yoshida Decreasing of p27Kip1 and cyclin E protein levels is associated with progression from superficial into invasive bladder cancer doi:10.1054/bjoc.2000.1736 Abstract | Full article | PDF |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
|
|
|
| |||
| Print ISSN: 0007-0920 | Online ISSN: 1532-1827 | © 2008 Cancer Research UK | ||
| |||
| Privacy Policy | |||